Endothelium-dependent and -independent vasorelaxation induced by CIJ-3-2F, a novel benzyl-furoquinoline with antiarrhythmic action, in rat aorta

Life Sciences

Volumn 86, Issue 23-24, 2010, Pages 869-879

  Chang, Gwo Jyh ^a   Lin, Tsung Ping ^b   Ko, Yu Shien ^c   Lin, Miao Sui ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Ca2+ channel; CIJ 3 2F; Endothelium; Furoquinoline; K+ channel; Patch clamp; Rat thoracic aorta; Vascular smooth muscle cells; Vasorelaxation

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4 AMINOPYRIDINE; ANTIARRHYTHMIC AGENT; APAMIN; CAFFEINE; CALCIUM CHANNEL L TYPE; CHARYBDOTOXIN; CIJ 3 2F; GLIBENCLAMIDE; HEMOGLOBIN; IBERIOTOXIN; INOSITOL 1,4,5 TRISPHOSPHATE; ION CHANNEL; METHYLENE BLUE; N (2 FLUOROBENZYL) 7 BROMO 2,3,4,9 TETRAHYDROFURO[2,3 B]QUINOLINE 3,4 DIONE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; N5 (1 IMINOETHYL)ORNITHINE; NITRIC OXIDE; PHENYLEPHRINE; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHLORIDE; TETRAMETHYLAMMONIUM; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; GENE ACTIVATION; MALE; MUSCLE CELL; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PATCH CLAMP; RAT; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULAR RING; VASCULAR SMOOTH MUSCLE; VASODILATATION;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANIMALS; ANTI-ARRHYTHMIA AGENTS; AORTA, THORACIC; CALCIUM; CALCIUM CHANNEL AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; MALE; MEMBRANE POTENTIALS; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION; VASODILATOR AGENTS;

RATTUS;

EID: 77953025116     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.03.020     Document Type: Article

References (34)

1. Ahn H.Y., Karaki H. Inhibitory effects of procaine on contraction and calcium movement in vascular and intestinal smooth muscles. British Journal of Pharmacology 1988, 94(3):789-796.
2. Chang G.J., Wu M.H., Chen W.P., Kuo S.C., Su M.J. Electrophysiological characteristics of antiarrhythmic potential of acrophyllidine, a furoquinoline alkaloid isolated from Acronychia halophylla. Drug Development Research 2000, 50(2):170-185.
3. Chang G.J., Su M.J., Kuo S.C., Lin T.P., Lee Y.S. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2, 3, 4, 9-tetrahydrofuro[2, 3-b]quinoline-3, 4-dione] in guinea pig cardiac preparations. Journal of Pharmacology and Experimental Therapeutics 2006, 316(1):380-391.
4. Chen W.J., Ho W.J., Chang G.J., Chen S.T., Pang J.H.S., Chou S.H., Tsay P.K., Kuo C.T. Propylthiouracil, independent of its antithyroid effect, produces endothelium-dependent vasodilatation through induction of nitric oxide bioactivity. Atherosclerosis 2008, 196(1):383-390.
5. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399(6736):601-605.
6. Fleming I., Bauersachs J., Busse R. Calcium-dependent and calcium-independent activation of the endothelial NO synthase. Journal of Vascular Research 1997, 34(3):165-174.
7. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., Franke T.F., Papapetropoulos A., Sessa W.C. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999, 399(6736):597-601.
8. Fulton D., Gratton J.P., Sessa W.C. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?. Journal of Pharmacology and Experimental Therapeutics 2001, 299(3):818-824.
9. Furchgott R.F. Role of endothelium in responses of vascular smooth muscle. Circulation Research 1983, 53(5):557-573.
10. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288(5789):373-376.
11. Horowitz A., Menice C.B., Laporte R., Morgan K.G. Mechanisms of smooth muscle contraction. Physiological Reviews 1996, 76(4):967-1003.
12. Huang A.C., Lin T.P., Kuo S.C., Wang J.P. The antiallergic activities of synthetic acrophylline and acrophyllidine. Journal of Natural Products 1995, 58(1):117-120.
13. 1-adrenergic receptor antagonist that relaxes vascular smooth muscle by nitric oxide- and cyclic GMP-dependent mechanisms. Nitric Oxide 2002, 7(2):75-77.
14. Ignarro L.J., Napoli C., Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circulation Research 2002, 90(1):21-28.
15. Karaki H., Ozaki H., Hori M., Mitsui-Saito M., Amano K., Harada K., Miyamoto S., Nakazawa H., Won K.J., Sato K. Calcium movements, distribution, and functions in smooth muscle. Pharmacological Reviews 1997, 49(2):157-230.
16. + channels in vascular smooth muscle cells. Journal of Smooth Muscle Research 2008, 44(2):65-81.
17. Leung F.P., Yung L.M., Yao X., Laher I., Huang Y. Store-operated calcium entry in vascular smooth muscle. British Journal of Pharmacology 2008, 153(5):846-857.
18. Lincoln T.M., Komalavilas P., Cornwell T.L. Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase. Hypertension 1994, 23(6 Pt. 2):1141-1147.
19. Moncada S., Higgs E.A. The discovery of nitric oxide and its role in vascular biology. British Journal of Pharmacology 2006, 147(S1):S193-S201.
20. Nelson M.T., Quayle J.M. Physiological roles and properties of potassium channels in arterial smooth muscle. The American Journal of Physiology: Cell Physiology 1995, 268(4 Pt. 1):C799-C822.
21. 2+ pools in rat aorta. Naunyn-Schmiedeberg's Archives of Pharmacology 1998, 357(2):92-99.
22. Palmer R.M.J., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 1988, 333(6174):664-666.
23. Ratz P.H., Berg K.M., Urban N.H., Miner A.S. Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus. The American Journal of Physiology: Cell Physiology 2005, 288(4):C769-C783.
24. Ritter J.M. Nebivolol: endothelium-mediated vasodilating effect. Journal of Cardiovascular Pharmacology 2001, 38(Suppl. 3):S13-S16.
25. + currents in smooth muscle cells from cerebral arteries. The American Journal of Physiology: Cell Physiology 1994, 267(6 Pt. 1):C1589-C1597.
26. 2+ levels in vascular smooth muscle of rat aorta. Naunyn-Schmiedeberg's Archives of Pharmacology 1988, 338(4):443-448.
27. Sausbier M., Schubert R., Voigt V., Hirneiss C., Pfeifer A., Korth M., Kleppisch T., Ruth P., Hofmann F. Mechanisms of NO/cGMP-dependent vasorelaxation. Circulation Research 2000, 87(9):825-830.
28. Shah M., Akar F.G., Tomaselli G.F. Molecular basis of arrhythmias. Circulation 2005, 112(16):2517-2529.
29. Su M.J., Chang G.J., Wu M.H., Kuo S.C. Electrophysiological basis for the antiarrhythmic action and positive inotropy of HA-7, a furoquinoline alkaloid derivative, in rat heart. British Journal of Pharmacology 1997, 122(7):1285-1298.
30. Triggle D.J. Calcium channel antagonists: clinical uses-past, present and future. Biochemical Pharmacology 2007, 74(1):1-9.
31. Vane J.R., Anggård E.E., Botting R.M. Regulatory functions of the vascular endothelium. New England Journal of Medicine 1990, 323(1):27-36.
32. Villar I.C., Francis S., Webb A., Hobbs A.J., Ahluwalia A. Novel aspects of endothelium-dependent regulation of vascular tone. Kidney International 2006, 70(5):840-853.
33. Wier W.G., Morgan K.G. Alpha1-adrenergic signaling mechanisms in contraction of resistance arteries. Reviews of Physiology Biochemistry and Pharmacology 2003, 150(1):91-139.
34. 2+ channel blockers. Naunyn-Schmiedeberg's Archives of Pharmacology 1992, 345(3):349-355.